3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
32
Brain Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
17
Lung Neoplasms
15
Carcinoma, Hepatocellular
13
Breast Neoplasms
10
Pancreatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Neoplasms
7
Colorectal Neoplasms
7
Spinal Cord Neoplasms
3
Small Cell Lung Carcinoma
3
Prostate Cancer Metastatic
3
Nasopharyngeal Carcinoma
3
Kidney Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Unresectable Locally Recurrent Rectal Cancer
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroma, Acoustic
2
Neoplasms by Site
2
Klatskin Tumor
2
Head and Neck Neoplasms
2
Interventions
enzalutamide
5
darolutamide
4
Docetaxel
3
Prednisone
2
olaparib
1
gedatolisib
1
fludrocortisone acetate
1
cabazitaxel
1
abiraterone
1
TVB-2640
1
Radiosurgery
1
Omeprazole
1
Dexamethasone
1
Androgen Antagonists
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Prostatic Neoplasms, Castration-Resistant
×
Radiosurgery
×
Clear all
NCT06276465
2024-12-20
PEACE8
UNICANCER
Phase 3
Recruiting
336 enrolled